Clayton Financial Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-42
Closed -$3.64K 373
2026
Q1
$3.64K Hold
42
﹤0.01% 369
2025
Q4
$4.04K Buy
+42
New +$4.08K ﹤0.01% 345
2025
Q2
Sell
-2,465
Closed -$222K 75
2025
Q1
$222K Buy
+2,465
New +$221K 0.08% 110

Other funds holding MDT

Clayton Financial Group's MDT Position: Q2 2026 in Review

Clayton Financial Group sold out of Medtronic (MDT) in Q2 2026, closing a stake of 42 shares — an estimated $3.64K sold.

Clayton Financial Group first reported a position in MDT in Q1 2025 and held it in 3 quarters. The position peaked at $222K in Q1 2025. 734 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Clayton Financial Group reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Clayton Financial Group sold 42 Medtronic shares in Q2 2026, an estimated $3.64K.
  • Clayton Financial Group first reported a position in Medtronic in Q1 2025 and held it in 3 quarters.
  • Clayton Financial Group's Medtronic position peaked at $222K in Q1 2025.
  • 734 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Clayton Financial Group's 13F filing for Q2 2026, filed 20 Jul 2026.